UAB Vitacon VitaScan PD Ultrasound Bladder Scanner 新加坡 - 英文 - HSA (Health Sciences Authority)

uab vitacon vitascan pd ultrasound bladder scanner

fortuna scientific private ltd. - radiology / imaging - the vitascan pd projects ultrasound energy through the lower abdomen of the patient to obtain an image of the bladder. this image is used to determine bladder volume non-invasively.

Propofol 10mg/ml Emulsion for injection/infusion 马耳他 - 英文 - Medicines Authority

propofol 10mg/ml emulsion for injection/infusion

uab norameda - propofol - emulsion for infusion or injection - propofol 10 milligram(s)/millilitre - anesthetics

Propofol 20mg/ml Emulsion for injection/infusion 马耳他 - 英文 - Medicines Authority

propofol 20mg/ml emulsion for injection/infusion

uab norameda - propofol - emulsion for infusion or injection - propofol 20 milligram(s)/millilitre - anesthetics

Telemed UAB SmartUs EXT-3M Ultrasound Diagnostic System 新加坡 - 英文 - HSA (Health Sciences Authority)

telemed uab smartus ext-3m ultrasound diagnostic system

biobot surgical pte. ltd. - radiology / imaging - smartus ext-3m ultrasound imaging system is intended to be used for applications in fetal, abdominal, pediatric, small organ (breast, thyroid, testicles), musculo-skeletal (conventional), musculo-skeletal (superficial), cardiac adult, cardiac pediatric, adult cephalic, peripheral vessel (b- and m-mode, combined modes imaging, including imaging for needle guidance), trans-rectal and trans-vaginal examinations. it is possible to provide diagnostic information outside of an imaging lab, including at the bedside systems, for navigated medical application, in operating rooms/critical care units.

LINEZOLID 2 Mg/Ml Solution for Infusion 爱尔兰 - 英文 - HPRA (Health Products Regulatory Authority)

linezolid 2 mg/ml solution for infusion

claris lifesciences (uk) limited - linezolid - solution for infusion - 2 mg/ml - other antibacterials

LANOXIN PG digoxin 62.5microgram tablet bottle 澳大利亚 - 英文 - Department of Health (Therapeutic Goods Administration)

lanoxin pg digoxin 62.5microgram tablet bottle

aspen pharma pty ltd - digoxin, quantity: 0.0625 mg - tablet, uncoated - excipient ingredients: lactose monohydrate; maize starch; magnesium stearate; povidone; indigo carmine; oxidised maize starch; rice starch - indications as at 26 july 2000 : congestive heart failure - lanoxin is useful regardless of whether the failure is predominantly of the left or right ventricle, or involves both sides of the heart. it is particularly useful in heart failure resulting from chronic overload (hypertension, valvular lesions, atherosclerotic heart disease) in which the supply of energy is not impaired. lanoxin does not cause major benefit in situations in which the metabolic energy supply is compromised as in thyrotoxicosis, hypoxia, and severe thiamine deficiency. atrial fibrillation - because lanoxin depresses conduction in the atrioventricular bundle, producing a slower ventricular beat, it is valuable in atrial fibrillation. it will frequently convert atrial flutter into fibrillation and, upon withdrawal of the drug, normal sinus rhythm may be restored. paroxysmal atrial tachycardia - lanoxin may relieve or prevent an attack, but its use in paroxysmal ventricular tachycardia is dangerous.

Lanoxin Adult 500mcg/2mL injection ampoule 澳大利亚 - 英文 - Department of Health (Therapeutic Goods Administration)

lanoxin adult 500mcg/2ml injection ampoule

aspen pharma pty ltd - digoxin, quantity: 0.25 mg/ml - injection, solution - excipient ingredients: citric acid monohydrate; dibasic sodium phosphate; propylene glycol; water for injections; ethanol - indications as at 26 july 2000 : congestive heart failure - lanoxin is useful regardless of whether the failure is predominantly of the left or right ventricle, or involves both sides of the heart. it is particularly useful in heart failure resulting from chronic overload (hypertension, valvular lesions, atherosclerotic heart disease) in which the supply of energy is not impaired. lanoxin does not cause major benefit in situations in which the metabolic energy supply is compromised as in thyrotoxicosis, hypoxia, and severe thiamine deficiency. atrial fibrillation - because lanoxin depresses conduction in the atrioventricular bundle, producing a slower ventricular beat, it is valuable in atrial fibrillation. it will frequently convert atrial flutter into fibrillation and, upon withdrawal of the drug, normal sinus rhythm may be restored. paroxysmal atrial tachycardia - lanoxin may relieve or prevent an attack, but its use in paroxysmal ventricular tachycardia is dangerous.